| Number of | Percent with outcome | |||||
|---|---|---|---|---|---|---|
| Outcome - daily dose | Studies | Participants | Pregabalin | Placebo | Relative benefit (95% CI) | NNT (95% CI) |
| At least 30% pain relief | ||||||
| 600 mg | 1 | 136 | 42 | 13 | 3.1 (1.6 to 6.1) | 3.5 (2.3 to 7.0) |
| At least 50% pain relief | ||||||
| 600 mg | 2 | 176 | 25 | 7 | 3.6 (1.5 to 8.4) | 5.6 (3.5 to 14) |
| Lack of efficacy discontinuation | NNTp (95% CI) | |||||
| 600 mg | 2 | 177 | 6 | 24 | 0.3 (0.1 to 0.6) | 5.4 (3.5 to 12) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.